These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34609382)
21. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma. Hesse L; Petersen AH; Nawijn MC Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602 [TBL] [Abstract][Full Text] [Related]
22. Allergen Immunotherapy for Local Respiratory Allergy. Eguiluz-Gracia I; Ariza A; Testera-Montes A; Rondón C; Campo P Curr Allergy Asthma Rep; 2020 May; 20(7):23. PubMed ID: 32430550 [TBL] [Abstract][Full Text] [Related]
23. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview. Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981 [TBL] [Abstract][Full Text] [Related]
24. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis. Bożek A; Kołodziejczyk K; Jarząb J Ann Allergy Asthma Immunol; 2018 Jan; 120(1):53-58. PubMed ID: 29273130 [TBL] [Abstract][Full Text] [Related]
26. Changes in CD4+CD25+FoxP3+ Regulatory T Cells and Serum Cytokines in Sublingual and Subcutaneous Immunotherapy in Allergic Rhinitis with or without Asthma. Xian M; Feng M; Dong Y; Wei N; Su Q; Li J Int Arch Allergy Immunol; 2020; 181(1):71-80. PubMed ID: 31722337 [TBL] [Abstract][Full Text] [Related]
27. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma. Richards JR; Stumpf JL Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713 [TBL] [Abstract][Full Text] [Related]
28. The role of allergen immunotherapy in the management of allergic rhinitis. Cox L Am J Rhinol Allergy; 2016; 30(1):48-53. PubMed ID: 26867530 [TBL] [Abstract][Full Text] [Related]
29. Real-world evidence for the long-term effect of allergen immunotherapy: Current status on database-derived European studies. Vogelberg C; Klimek L; Brüggenjürgen B; Jutel M Allergy; 2022 Dec; 77(12):3584-3592. PubMed ID: 36074052 [TBL] [Abstract][Full Text] [Related]
30. Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis. Đurić-Filipović I; Caminati M; Kostić G; Filipović Đ; Živković Z World J Pediatr; 2016 Aug; 12(3):283-290. PubMed ID: 27351563 [TBL] [Abstract][Full Text] [Related]
31. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
32. [Short-term efficacy and safety observation of standardized mite allergen extract rush subcutaneous immunotherapy for allergic rhinitis: a prospective study]. Huang JY; Zhang W; Xiang R; Deng YQ; Tao ZZ; Xu Y Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 58(9):854-862. PubMed ID: 37675523 [No Abstract] [Full Text] [Related]
33. Sublingual immunotherapy for allergic rhinitis. Wilson DR; Torres LI; Durham SR Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442 [TBL] [Abstract][Full Text] [Related]
34. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis]. You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014 [No Abstract] [Full Text] [Related]
35. Subcutaneous immunotherapy for allergic rhinitis: an evidence based review of the recent literature with recommendations. Purkey MT; Smith TL; Ferguson BJ; Luong A; Reisacher WR; Pillsbury HC; Toskala E Int Forum Allergy Rhinol; 2013 Jul; 3(7):519-31. PubMed ID: 23315962 [TBL] [Abstract][Full Text] [Related]
36. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy. Liu Y; Xing Z; Wang J; Geng C Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065 [TBL] [Abstract][Full Text] [Related]
37. Local allergic rhinitis: Implications for management. Campo P; Eguiluz-Gracia I; Bogas G; Salas M; Plaza Serón C; Pérez N; Mayorga C; Torres MJ; Shamji MH; Rondon C Clin Exp Allergy; 2019 Jan; 49(1):6-16. PubMed ID: 29900607 [TBL] [Abstract][Full Text] [Related]
38. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Sayed KM; Kamel AG; Ali AH Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1989-1996. PubMed ID: 31209565 [TBL] [Abstract][Full Text] [Related]
39. Efficacy, patients' perception, and cost of medication in allergic rhinitis with subcutaneous immunotherapy. Thanborisutkul K; Khodtecha N; Kulalert P; Sritipsukho P Asian Pac J Allergy Immunol; 2023 Sep; 41(3):199-205. PubMed ID: 32828119 [TBL] [Abstract][Full Text] [Related]
40. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma. Passalacqua G; Canonica GW; Bagnasco D Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]